From Product Launches To Toll Manufacturing, Japanese Giant Takeda Unveils Plans For India
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Almost a year after naming former Roche executive Shankar Suryanarayanan as head of its Indian operations, Japan's largest drug maker Takeda has unveiled "medium- to long-term strategies" for its business expansion - one of which is to launch its products in the burgeoning Indian market
You may also be interested in...
Are Stars Finally Aligning For Takeda In India?
For the past four years, Takeda’s plans for a full-scale entry into India have remained just that – plans on paper. But will it be a laggard for much longer in this fast-changing key emerging market? There are signs that the time may now be ripe for Japan’s top pharma firm to take a more decisive plunge.
Takeda Takes First Steps In India, But How Far Will It Go?
Takeda’s plans for India are slowly taking shape, but whether it will gain speed via buyouts or go the brick- and-mortar route is the big question.
To Boost Productivity, India’s Advinus, Takeda Team Up For R&D Across Therapies
Takeda looks to ride on Advinus’ broad early-stage pipeline while also generating new INDs.